Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists-Reference-Cited by-同舟云学术

Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists

Published:2004-05 Issue:10 Volume:14 Page:2451-2457
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Rueeger Heinrich,Gerspacher Marc,Buehlmayer Peter,Rigollier Pascal,Yamaguchi Yasuchika,Schmidlin Tibur,Whitebread Steven,Nuesslein-Hildesheim Barbara,Nick Hanspeter,Cricione Leoluca

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference22 articles.

1. Chapter 1. Neuropeptide Y: At The Dawn Of Subtype Selective Antagonists

2. Neuropeptide Y and Drug Development,1997

3. Multiple Receptors for the Pancreatic Polypeptide (PP-Fold) Family: Physiological Implications

4. Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y 5 receptor antagonists

5. α-Substituted N-(Sulfonamido)alkyl-β-aminotetralins: Potent and Selective Neuropeptide Y Y5 Receptor Antagonists

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological evaluation of benzosuberones;Expert Opinion on Therapeutic Patents;2017-10-24

2. Synthetic routes to benzosuberone-based fused- and spiro-heterocyclic ring systems;RSC Advances;2016

3. Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status;Mini-Reviews in Medicinal Chemistry;2014-10-31

4. Adaptation of High-Throughput Screening in Drug Discovery—Toxicological Screening Tests;International Journal of Molecular Sciences;2011-12-29

5. Discovery of Lu AA33810: A highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder;Bioorganic & Medicinal Chemistry Letters;2011-09